UC Davis BioPortal

Boehringer Ingelheim Vetmedica, Inc. (BIVI) supports the UC Davis Disease BioPortal, operated and maintained by the Center for Animal Disease Modeling and Surveillance at the University of California, Davis. The BioPortal provides disease detection, analysis, and communication within the animal health industry.

Beef Quality Assurance (BQA)

BIVI is proud to partner with the National Cattlemen's Beef Association Beef Quality Assurance (BQA) program and its efforts within the cattle industry to educate and certify producers and their staff on best practices for cattle production. BQA certification helps producers demonstrate their commitment to excellence in beef production.

Equine Endocrinology Summit

BIVI supports the Equine Endocrinology Group (EEG) annual meeting of clinicians and researchers from different countries to discuss specific topics and present current research on equine endocrine disorders.

ISO Accredited Diagnostic Lab (HMC)

BIVI’s Health Management Center (HMC) facilitates the continual improvement of health, performance, and quality for the pork industry. Since 2004, BIVI HMC has been ISO 17025 accredited by the American Associated of Laboratory Accreditation. Laboratories that are accredited to this international standard have demonstrated that they are technically competent and are able to produce precise and accurate test and/or calibration data.

"A shot at life"

We’ve joined with the Petfinder Foundation and The Animal Rescue Site for “A Shot at Life … Join the 2 Million Pet Challenge!” to help vaccinate 25 percent of the shelter population.

Learn more about the challenge by visiting PetFinderFoundation.com or TheAnimalRescueSite.com.

Get the most possible with consistent therapy.

The Partners in Compliance™ program is a rewarding way to keep METACAM therapy on track.

  • Offers $5 or $10 rebates for each METACAM bottle purchased by the dog owner
  • Provides helpful tips and reminder emails to encourage compliance with the recommended pain management regimen.
Enroll in the Partners in Compliance program to help your customers receive up to $10 on each METACAM prescription.

Important Safety Information: As a class, cyclo-oxygenase inhibitory NSAIDs may be associated with gastrointestinal, kidney, or liver side effects. The most common side effects reported in field studies were vomiting and soft stool/diarrhea. These are usually mild, but may be serious. If side effects occur, pet owners should halt therapy and contact their veterinarian. Pets should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with METACAM, then monitored regularly while on treatment. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided.

The safe use of METACAM Oral Suspension and Solution for Injection in dogs younger than 6 months of age, dogs used for breeding, or in pregnant or lactating dogs has not been evaluated.

The safe use of Metacam 5 mg/mL Solution for Injection in cats younger than 4 months of age, cats used for breeding, or in pregnant or lactating queens has not been evaluated. Repeated use of meloxicam in cats has been associated with acute renal failure and death. Do not administer a second dose of meloxicam. Do not follow meloxicam dose with any other NSAID.

R&D Partners

Potential research partners can submit their opportunities for consideration on our online portal. An initial assessment of how your opportunity might fit relative to our business strategy will typically be provided within 5 business days.